Skip to main content

Table 4 Bone remodeling factors in JDM patients and controls

From: Bone mineral density and explanatory factors in children and adults with juvenile dermatomyositis at long term follow-up; a cross sectional study

 

Patients (n = 55–58)

Controls (n = 55–58)

p-values

CTX, ug/l

0.51 (0.34–0.97)

0.46 (0.30–0.96)

0.34

P1NP, ug/l

73.0 (46.8–318.0)

75.0 (52.8–352.0)

0.63

25-OH-VitD, nmol/l

54.0 (37.0–65.0)

65.0 (45.0–83.0)

0.001

Low 25(OH)VitD (<  37 nmol/l), n

13 (22.4)

4 (6.9)

0.08

Insufficient 25(OH)VitD (<20nmo/l), n

3 (5.5)

0 (0)

0.02

Calsium, nmol/l

2.29 (2.24–2.33)

2.33 (2.29–2.39)

0.001

iCalsium, nmol/l

1.25 (0.04)

1.25 (0.03)

0.83

Albumin, g/l

44.5 (2.3)

45.9 (2.3)

0.002

Alkaline phosphatase, U/l

71.0 (56.0–147.3)

72.00 (55.0–150.8)

0.97

Phosphate, nmol/l

1.23 (0.25)

1.13 (0.21)

0.005

PTH, pmol/l

3.52 (1.19)

3.53 (1.27)

0.95

E-SR, mm/h

5.0 (3.0–9.0)

4.0 (3.0–8.0)

0.06

hsCRP, mg/l

0.98 (0.28–2.6)

0.59 (0.23–1.27)

0.12

IP-10, pg/ml

1009 (911–1581)

969 (751–1187)

0.04

Age < 20 y

(n = 25–28)

(n = 25–28)

 

CTX, ug/l

0.94 (0.55–1.39)

0.97 (0.49)1.22

0.73

P1NP, ug/l

326.0 (95.0–560.78)

397.0 (95.0–608.7)

0.77

25-OH-VitD, nmol/l

55.4 (19.0)

66.2 (24.4)

0.11

Low 25(OH)VitD (< 37 nmol/l), n

6 (21.4)

2 (7.1)

0.31

Insufficient 25-OH-VitD (<20 nmol/l), n

1 (3.7)

0 (0)

0.13

Calsium, nmol/l

2.3 (0.2)

2.3 (0.01)

0.18

iCalsium, nmol/l

1.26 (0.03)

1.26 (0.03)

0.75

Albumin, g/l

44.8 (2.1)

45.8 (2.1)

0.10

Alkaline phosphatase, U/l

149.5 (74.3–226.8)

152.5 (76.5–194.8)

0.60

Phosphate, nmol/l

1.35 (0.23)

1.23 (0.23)

0.005

PTH, pmol/l

3.55 (1.23)

3.32 (1.28)

0.50

E-SR, mm/h

4.50 (3.00–8.25)

4.50 (3.00–10.50)

0.44

hsCRP, mg/l

0.40 (0.24–2.44)

0.35 (0.19–1.27)

0.43

IP-10, pg/ml

982 (855–1479)

889 (732–1125)

0.14

Age ≥ 20 y

(n = 28–30)

(n = 28–30)

 

CTX, ug/l

0.40 (0.24–0.49)

0.32 (0.23–0.41)

0.16

P1NP, ug/l

55.0 (41.8–59.0)

59.0 (42.8–68.0)

0.23

25(OH)VitD, nmol/l

47.3 (17.2)

65.3 (21.4)

0.001

Low 25(OH)VitD (< 0.37 nmol/l), n

7 (23.3)

2 (6.7)

0.15

Insufficient 25(OH)VitD (<20 nmol/l), n

2 (7.1)

0 (0)

0.07

Calsium, nmol/l

2.25 (0.11)

2.34 (0.09)

0.002

iCalsium, nmol/l

1.24 (0.04)

1.24 (0.03)

0.62

Albumin, g/l

44.3 (2.5)

46.0 (2.5)

0.004

Alkaline phosphatase, U/l

61.0 (49.0–73.3)

59.0 (50.0–70.5)

0.66

Phosphate,nmol/l

1.10 (0.22)

1.03 (0.17)

0.15

PTH, pmol/l

3.5 (1.17)

3.73 (1.44)

0.48

E-SR, mm/h

7.0 (3.0–8.5)

4.0 (3.0–8.0)

0.08

hsCRP, mg/l

1.07 (0.43–3.5)

0.63 (0.33–1.27)

0.15

IP-10, pg/ml

1066 (940–1593)

1041 (764–1201)

0.14

  1. CTX C-terminal collagen crosslinks, P1NP pro-collagen type 1 N-terminal pro-peptide, 25-OH-VitD 25-hydroxyvitamin D, insufficient 25(−OH)-VitD <20 nmol/l; Low 25(OH)VitD, n < 37 nmol/l; iCalsium: ionized calcium, PTH parathyroid hormone, E-SR erythrocyte sedimentation rate, hsCRP high sensitive C-reactive protein, IP-10 Interferon gamma-induced protein 10. Values are mean (SD) or median (IQR). P-values when comparing patients and controls using independent samples t-test or chi-square for nonparametric values